SMARCA4 and undifferentiated carcinoma: Inactivation of SMARCA4 (BRG1) has been suggested to be involved in the pathogenesis of some undifferentiated carcinomas of the lung, ovary, gastrointestinal tract, uterus, and other organs (14).